Recent Updates
Recently added Catalysts
ELVN Positive Sentiment Score: 70/100

Enliven Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and...

Key Takeaway: Enliven Therapeutics, Inc. (Nasdaq: ELVN) will present at the TD Cowen 45th Annual Health Care Conference on March 4, 2025. The event will include a fireside chat with the company's management, which will be available for live streaming. Additionally, the webcast will be accessible for 90 days after the live session, allowing for broader access to information about the company's developments.

Market Sentiment Analysis

POSITIVE FACTORS

  • Enliven Therapeutics is actively engaging in important industry conferences.
  • The live webcast offers an opportunity for wider audience reach.
  • Management's participation could enhance investor interest.

Full Press Release Details

BOULDER, Colo. , Feb. 25, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN ), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that management will participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on Tuesday, March 4, 2025 , at 10:30 a.m. ET .
The fireside chat will be webcast live and can be accessed by visiting the investor relations section of the Company's website at https://ir.enliventherapeutics.com/ . The webcast will be archived for a period of 90 days following the conclusion of the live event.
SOURCE Enliven Therapeutics, Inc.

21 %

Frequently Asked Questions

When is the fireside chat for Enliven Therapeutics?

The fireside chat is scheduled for March 4, 2025, at 10:30 a.m. ET.

How can I watch the Enliven fireside chat?

The chat will be available live on their investor relations website.

Will the fireside chat be available later?

Yes, an archived version will be accessible for 90 days post-event.

What type of company is Enliven Therapeutics?

Enliven Therapeutics is a clinical-stage biopharmaceutical company.

Where can I find more information about the event?

More details can be found on the investor relations section of their website.

Last updated: Feb 25, 2025